Home/ Stocks/ NNVC

NanoViricides Inc.

NNVC XASE

$1.55 +0.13 (+9.15%) ▲ 15-min delayed

Open

$1.44

High

$1.55

Low

$1.40

Volume

426.1K

Market Cap

$33.47M

About NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 7 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$0	$-2,220,719	$-0.11
Q1 2026	$0	$-1,785,058	$-0.10
FY 2025	$0	$-9,466,966	$-0.63
Q3 2025	$0	$-2,216,783	$-0.14

Related Market News

No specific coverage for NNVC yet. Check out our latest market news or earnings calendar.

Get NNVC Alerts

Stay ahead with breaking news, price alerts, and expert analysis on NanoViricides Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.